Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             135 results found
no title author magazine year volume issue page(s) type
1 13 ACUTE HEPATITIS C IN HAEMODIALYSIS PATIENTS: NATURAL COURSE AND RESPONSE TO IFNα-MONOTHERAPY Fasano, M.
 2010
 42 S1 p. S5-S6
2 p.
 article
2 A.I.S.F. 2010 Abstracts Evaluation Procedure 2010
 42 S1 p. v-
1 p.
 article
3 28 ALLOGRAFT EXPRESSION OF INNATE IMMUNITY GENES INFLUENCES LIVER FIBROSIS PROGRESSION AND ACUTE CELLULAR REJECTION IN LIVER TRANSPLANTED PATIENTS Fumolo, E.
 2010
 42 S1 p. S11-S12
2 p.
 article
4 12 A REDUCED REGULATORY ACTIVITY AND PREDOMINANCE OF THE GAMMA-DELTA VDELTA1 SUBSET CHARACTERISE PATIENTS WITH HCV-RELATED TYPE 2 CRYOGLOBULINEMIA Ferri, S.
 2010
 42 S1 p. S5-
1 p.
 article
5 Author index 2010
 42 S1 p. S53-S60
8 p.
 article
6 2 BETA-GLOBIN MUTATIONS ARE ASSOCIATED WITH PARENCHYMAL SIDEROSIS AND FIBROSIS SEVERITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE Canavesi, E.
 2010
 42 S1 p. S1-
1 p.
 article
7 5 BETTER SUSTAINED CONTROL OF CHRONIC GENOTYPE 1 HCV INFECTIONS WITH PEG-IFN ALFA-2A THAN WITH PEG-IFN ALFA-2B TREATMENT: RESULTS OF DAILY CLINICAL PRACTICE Orlandini, A.
 2010
 42 S1 p. S2-S3
2 p.
 article
8 22 BIOMOLECULAR EXPRESSION OF TARGET RECEPTORS OF CALCIMIMETIC AGENTS IN EXPERIMENTAL LIVER CIRRHOSIS: A NEW STRATEGY TO REDUCE PORTAL PRESSURE Sansoè, G.
 2010
 42 S1 p. S9-
1 p.
 article
9 32 CANCER-ASSOCIATED FIBROBLAST (CAF) RECRUITMENT IS MEDIATED BY PARACRINE PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALLING IN CHOLANGIOCARCINOMA Cadamuro, M.
 2010
 42 S1 p. S13-
1 p.
 article
10 33 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMENT Alvaro, D.
 2010
 42 S1 p. S13-S14
2 p.
 article
11 31 CLINICAL EFFICACY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATED WITH COVERED STENTS WITH DIFFERENT DIAMETERS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL Riggio, O.
 2010
 42 S1 p. S13-
1 p.
 article
12 18 DRUG TRANSPORTER GENE POLYMORPHISM PREDICTS RENAL TUBULAR TOXICITY IN PATIENTS WITH CHRONIC HEPATITIS B ON LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION Viganò, M.
 2010
 42 S1 p. S8-
1 p.
 article
13 24 EARLY USE OF MYCHOPHENOLATE MOFETIL IS A MAJOR DETERMINANT OF ONE YEAR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: RESULTS FROM THE LIVER MATCH PROSPECTIVE COHORT STUDY Angelico, M.
 2010
 42 S1 p. S10-
1 p.
 article
14 6 EPIDEMIOLOGICAL CHANGES OF BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: A CURRENT CLINICAL PROBLEM Cazzaniga, M.
 2010
 42 S1 p. S3-
1 p.
 article
15 14 ESTROGEN RECEPTOR β SELECTIVE AGONISTS EXERT ANTI-CANCER ACTIVITY ON EXPERIMENTAL INTRA-HEPATIC CHOLANGIOCARCINOMA: AN IN VITRO AND IN VIVO STUDY Marzioni, M.
 2010
 42 S1 p. S6-
1 p.
 article
16 F.N.37 ACCURATE INDIVIDUALIZATION OF PEG-IFN+RBV TREATMENT DURATION BY HCV INFECTED CELL DECLINE COMPUTED IN THE 1ST MONTH OF THERAPY Colombatto, P.
 2010
 42 S1 p. S46-S47
2 p.
 article
17 F.N.5 ADRENAL DYSFUNCTION IN CIRRHOSIS: PREVALENCE AND IMPACT ON SURVIVAL IN NONSEPTIC PATIENTS WITH ASCITES Mezzabotta, L.
 2010
 42 S1 p. S34-
1 p.
 article
18 F.N.14 ALGORITHM FOR THE TREATMENT OF PORTAL (PVT) AND SPLANCNINC VEINS THROMBOSIS (SVT) IN PATIENTS WITH LIVER CIRRHOSIS Senzolo, M.
 2010
 42 S1 p. S38-
1 p.
 article
19 F.N.49 A MODIFIED CHILD–TURCOTTE–PUGH (CTP) FOR SELECTION OF CANDIDATES TO LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD) Gitto, S.
 2010
 42 S1 p. S51-
1 p.
 article
20 F.N.11 ANTICOAGULANT TREATMENT FOR NOT NEOPLASTIC PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND ESOPHAGEAL VARICES Butera, G.
 2010
 42 S1 p. S37-
1 p.
 article
21 F.N.12 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES Dionigi, E.
 2010
 42 S1 p. S37-
1 p.
 article
22 F.N.4 CAN NON-INVASIVE METHODS PREDICT ESOPHAGEAL VARICES IN CHILDREN WITH BILIARY ATRESIA AFTER KASAY OPERATION? Colecchia, A.
 2010
 42 S1 p. S34-
1 p.
 article
23 F.N.46 CLINICAL CHARACTERISTICS AND OUTCOMES BY ETHNICITY AND RACE OF PATIENTS LISTED FOR LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS Bowlus, C.L.
 2010
 42 S1 p. S50-
1 p.
 article
24 F.N.43 COFFEE AND ITS COMPONENTS IN A RAT MODEL OF NASH Amoruso, D.C.
 2010
 42 S1 p. S49-
1 p.
 article
25 F.N.31 COULD MORE GENOTYPE-1 HCV PATIENTS COMPLETE FUTURE STAT-C REGIMENS IN REAL PRACTICE? Termini, R.
 2010
 42 S1 p. S44-S45
2 p.
 article
26 F.N.16 EFFECTIVENESS OF ENTECAVIR FOR NUC-NAIVE, HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: A 2-YEAR MULTICENTER COHORT STUDY IN 311 PATIENTS Lampertico, P.
 2010
 42 S1 p. S39-
1 p.
 article
27 F.N.26 EFFICACY OF SUPERSELECTIVE TACE IN TREATMENT OF HCC Terzi, E.
 2010
 42 S1 p. S42-S43
2 p.
 article
28 F.N.24 ERK5 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA (HCC), AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS Rovida, E.
 2010
 42 S1 p. S42-
1 p.
 article
29 F.N.22 FIELD PRACTICE WITH SORAFENIB IN ADVANCED HCC: EFFECTIVENESS CONFIRMED, TOLERABILITY REDUCED BUT USUALLY MANAGEABLE, COMPARED TO REGISTRATION TRIALS Iavarone, M.
 2010
 42 S1 p. S41-
1 p.
 article
30 F.N.21 HCV ENHANCES HEPATOMA CELLS INVASIVENESS REGULATING FOCAL ADHESION MOLECULES Alisi, A.
 2010
 42 S1 p. S41-
1 p.
 article
31 F.N.44 HEPATIC RETINOL BINDING PROTEIN 4 (RBP-4) LEVELS ARE SIGNIFICANTLY RELATED TO THE STEATOHEPATITIS GRADE (COMPROMISSION) BUT NOT WITH HCV INFECTION Persico, M.
 2010
 42 S1 p. S49-
1 p.
 article
32 F.N.38 HEPCIDIN EXPRESSION AT HEPATIC, SERUM AND URINARY LEVEL IN SUBJECTS WITH DIFFERENT IRON PHENOTYPES Pozzi, M.
 2010
 42 S1 p. S47-
1 p.
 article
33 F.N.39 HOMOZYGOSITY FOR THE PNPLA3/ADIPONUTRIN I148M POLYMORPHISM INFLUENCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE Valenti, L.
 2010
 42 S1 p. S47-
1 p.
 article
34 F.N.23 HYPOXIA UP-REGULATES SERPIN B3 IN HEPATIC CANCER CELLS BY A HIF-2α-DEPENDENT MECHANISM Paternostro, C.
 2010
 42 S1 p. S41-S42
2 p.
 article
35 F.N.35 IMMUNOLOGY IN LIVER TRANSPLANTATION FOR END-STAGE HCV-RELATED LIVER DISEASE: A PRELIMINARY STUDY ON T REGULATORY CELL KINETICS Ferri, S.
 2010
 42 S1 p. S46-
1 p.
 article
36 F.N.9 INCOMPLETE REVERSAL OF COGNITIVE DYSFUNCTION AFTER LIVER TRANSPLANTATION IN INDIVIDUALS WHO HAD HAD OVERT HEPATIC ENCEPHALOPATHY BEFORE LIVER TRANSPLANTATION Campagna, F.
 2010
 42 S1 p. S36-
1 p.
 article
37 F.N.40 INFLAMMATORY MOLECULES INVOLVED IN NON-ALCOHOLIC STEATOHEPATITIS IN RATS FED DIFFERENT DIETS Panera, N.
 2010
 42 S1 p. S47-S48
2 p.
 article
38 F.N.48 INFLUENCE OF DONOR–RECIPIENT VARIABLES ON SHORT TERM PATIENT SURVIVAL FOLLOWING LIVER TRANSPLANTATION (LT) Gambato, M.
 2010
 42 S1 p. S50-S51
2 p.
 article
39 F.N.8 INHIBITORY CONTROL TEST DOES NOT IDENTIFY THE PATIENTS AT RISK OF DEVELOPING OVERT HEPATIC ENCEPHALOPATHY (HE) IN AN ITALIAN POPULATION OF CIRRHOTIC PATIENTS Ridola, L.
 2010
 42 S1 p. S35-S36
2 p.
 article
40 F.N.29 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY Prati, G.M.
 2010
 42 S1 p. S44-
1 p.
 article
41 F.N.32 LIVER EXPRESSION OF RBP4 CORRELATES WITH LIVER DAMAGE IN CHRONIC HEPATITIS C AND IN NONALCOHOLIC FATTY LIVER DISEASE Petta, S.
 2010
 42 S1 p. S45-
1 p.
 article
42 F.N.42 LIVER STEATOSIS IN NORMAL WEIGHT SUBJECTS: PRELIMINARY RESULTS FROM A LARGE OBSERVATIONAL STUDY (BAGNACAVALLO STUDY) Dazzani, F.
 2010
 42 S1 p. S48-
1 p.
 article
43 F.N.34 LONG-TERM EVALUATION OF FIBROSIS BY TRANSIENT ELASTOGRAPHY IN PATIENTS CLEARING HCV ON ANTIVIRAL THERAPY Calvaruso, V.
 2010
 42 S1 p. S45-S46
2 p.
 article
44 F.N.33 LONG-TERM OUTCOME OF HCV-RELATED MIXED CRYOGLOBULINEMIA IN PATIENTS ACHIEVING SUSTAINED VIRAL RESPONSE (SVR) AFTER ANTIVIRAL THERAPY Petrarca, A.
 2010
 42 S1 p. S45-
1 p.
 article
45 F.N.1 MULTIPOTENT STEM CELLS RESIDE IN HUMAN EXTRAHEPATIC BILE DUCTS (hEHBDs) AND CAN GIVE RISE TO HEPATOCYTES, CHOLANGIOCYTES AND PANCREATIC ISLET CELLS Cardinale, V.
 2010
 42 S1 p. S33-
1 p.
 article
46 F.N.45 NAFLD PREVALENCE IN NEW DIAGNOSED CASES OF LIVER DISEASE IN SOUTHERN ITALY: RESULTS OF A PROSPECTIVE MULTICENTRIC STUDY Masarone, M.
 2010
 42 S1 p. S49-
1 p.
 article
47 F.N.20 NATURAL HISTORY AND MULTIMODALITY TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA PROSPECTIVELY DETECTED IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE Sangiovanni, A.
 2010
 42 S1 p. S40-
1 p.
 article
48 F.N.6 NEUTRAL ENDOPEPTIDASE (EC 3.4.24.11) INHIBITION BLUNTS ENDOTHELIN-1 PRODUCTION IN CIRRHOTIC RAT LIVERS: PHYSIOPATHOLOGICAL IMPLICATIONS Sansoè, G.
 2010
 42 S1 p. S35-
1 p.
 article
49 F.N.18 NEUTROPHIL PHAGOCYTIC DYSFUNCTION IN STABLE CIRRHOSIS IS INDEPENDENT OF BACTERIAL DNA AND ASSOCIATED WITH INCREASED EXPRESSION OF TLR-4 Tritto, G.
 2010
 42 S1 p. S39-S40
2 p.
 article
50 F.N.41 NON ALCOHOLIC FATTY LIVER DISEASE AND AGING. PREVALENCE AND ASSOCIATED FACTORS Bianchi, G.
 2010
 42 S1 p. S48-
1 p.
 article
51 F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA Minguzzi, M.
 2010
 42 S1 p. S43-
1 p.
 article
52 F.N.7 ONE-YEAR MORTALITY RATE IN PATIENTS WITH STAGE 3 AND 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (AISF)-EPASCO PROSPECTIVE MULTICENTRE STUDY Bruno, S.
 2010
 42 S1 p. S35-
1 p.
 article
53 F.N.2 PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS Cazzagon, N.
 2010
 42 S1 p. S33-
1 p.
 article
54 F.N.10 PHARMACOLOGICAL ANTAGONISM OF ENDOCANNABINOID CB1 RECEPTOR AMELIORATES LIVER FIBROSIS IN A RAT MODEL OF ADVANCED CIRRHOSIS Giannone, F.A.
 2010
 42 S1 p. S36-S37
2 p.
 article
55 F.N.17 PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? Ferraro, D.
 2010
 42 S1 p. S39-
1 p.
 article
56 F.N.13 PREVALENCE OF SPONTANEOUS HEPATIC-TO-HEPATIC VENOUS SHUNTS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION Bellis, L.
 2010
 42 S1 p. S37-S38
2 p.
 article
57 F.N.3 PROGENITOR CELL ACTIVATION AND LIVER REPAIR IS ALTERED IN NOTCH2- AND RBP-Jκ-DEFECTIVE MICE EXPOSED TO CHOLESTATIC INJURIES Fiorotto, R.
 2010
 42 S1 p. S33-S34
2 p.
 article
58 F.N.15 REACTIVATION OF HEPATITIS B OR C IN PATIENTS WITH IBD, UNDERGOING IMMUNOSUPPRESSIVE THERAPY. AN ITALIAN RETROSPECTIVE MULTICENTRE STUDY Morisco, F.
 2010
 42 S1 p. S38-S39
2 p.
 article
59 F.N.47 REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION Corradini, S. Ginanni
 2010
 42 S1 p. S50-
1 p.
 article
60 F.N.19 ROLE OF ADVANCED CYTOLOGY FOR THE DIAGNOSIS OF MALIGNANT BILE DUCT STRICTURES IN PATIENTS WITH JAUNDICE Sartori, M.
 2010
 42 S1 p. S40-
1 p.
 article
61 F.N.28 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH ON DEVELOPMENT OF DIARRHEA IN HCC PATIENTS TREATED WITH SORAFENIB Novi, M.
 2010
 42 S1 p. S43-
1 p.
 article
62 F.N.25 THREE CM OR LESS SINGLE HEPATOCELLULAR CARCINOMA: A RANDOMIZED CONTROLLED TRIAL COMPARING PERCUTANEOUS ETHANOL INJECTION VERSUS PERCUTANEOUS RADIOFREQUENCY ABLATION Giorgio, A.
 2010
 42 S1 p. S42-
1 p.
 article
63 F.N.30 TREATMENT OF CHRONIC HEPATITIS C WITH PEG-INF-α PLUS RIBAVIRIN DOESN'T ALTER FLUOXETINE DISPOSAL Soardo, G.
 2010
 42 S1 p. S44-
1 p.
 article
64 F.N.36 TREATMENT WITH INTERFERON (IFN) PLUS RIBAVIRIN (RBV) OF β-THALASSEMIC PATIENTS WITH HCV CHRONIC HEPATITIS DeSantis, A.
 2010
 42 S1 p. S46-
1 p.
 article
65 29 FROM NAFLD TO HCC: THE ROLE OF FIBROSIS AS A COFACTOR IN A NEW MOUSE MODEL De Minicis, S.
 2010
 42 S1 p. S12-
1 p.
 article
66 19 HBsAg SERUM LEVELS NEGATIVELY AFFECT HBV SPECIFIC IMMUNE RESPONSE Loggi, E.
 2010
 42 S1 p. S8-
1 p.
 article
67 21 HETEROGENEITY OF STEM-LIKE CELLS IN HEPATOCELLULAR CARCINOMA Mazzucchelli, S.
 2010
 42 S1 p. S9-
1 p.
 article
68 30 HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCC AND LIVER CIRRHOSIS Ventura, P.
 2010
 42 S1 p. S12-
1 p.
 article
69 9 HOST GENETIC DETERMINANTS IN HCV-RELATED MIXED CRYOGLOBULINEMIA Gragnani, L.
 2010
 42 S1 p. S4-
1 p.
 article
70 3 IMPROVED IN VITRO HBV REPLICATION IN HuH7 CELL LINE TRANSFECTED WITH FULL LENGTH CIRCULAR CLOSED HBV DNA BY MODIFICATIONS OF THE GUNTHER'S METHOD Cavallone, D.
 2010
 42 S1 p. S2-
1 p.
 article
71 27 LIVER CANCER STEM CELLS MIGHT BE IDENTIFIED BY THEIR LOW CONTENT OF REACTIVE OXYGEN SPECIES: IMPLICATIONS FOR HEPATIC TUMOR TREATMENT Piscaglia, A.C.
 2010
 42 S1 p. S11-
1 p.
 article
72 34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT Fornari, F.
 2010
 42 S1 p. S14-
1 p.
 article
73 26 PLATELET COUNT/SPLEEN DIAMETER RATIO COMPARED TO HVPG AND TRANSIENT ELASTOGRAPHY TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS De Bernardi Venon, W.
 2010
 42 S1 p. S11-
1 p.
 article
74 8 PREDICTING MORTALITY RISK IN CIRRHOTIC PATIENTS SINCE THE FIRST DECOMPENSATION BASED ON A NEW PROGNOSTIC SCORE: THE AISF-EPASCO PROSPECTIVE MULTICENTRE STUDY Bruno, S.
 2010
 42 S1 p. S3-S4
2 p.
 article
75 17 PRES-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBsAg IN ACTIVE HBV INFECTIONS Pollicino, T.
 2010
 42 S1 p. S7-S8
2 p.
 article
76 16 PREVALENCE AND RISK FACTOR OF HBV INFECTION AMONG 4959 IMMIGRANTS FROM NON EU COUNTRIES IN ITALY Pezzoli, M.C.
 2010
 42 S1 p. S7-
1 p.
 article
77 23 RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION Corradini, S. Ginanni
 2010
 42 S1 p. S10-
1 p.
 article
78 7 REDUCED FGF-21 EXPRESSION IN LIVER OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE Soardo, G.
 2010
 42 S1 p. S3-
1 p.
 article
79 10 SPLEEN STIFFNESS CORRELATES WITH PORTAL HYPERTENSION AND INCREASES THE ACCURACY OF DETECTION OF ESOPHAGEAL VARICES IN HCV CIRRHOSIS Calvaruso, V.
 2010
 42 S1 p. S4-S5
2 p.
 article
80 4 SUCCESSFUL ISOLATION, CULTURING AND DIFFERENTATION OF HEPATIC PROGENITOR CELLS (HPC) FROM HUMAN FOETAL LIVERS Alvaro, D.
 2010
 42 S1 p. S2-
1 p.
 article
81 15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208 Colombo, M.
 2010
 42 S1 p. S6-S7
2 p.
 article
82 35 THE NATURAL HISTORY OF HEPATIC MACROREGENERATIVE NODULES DEVELOPING IN CIRRHOTIC PATIENTS DURING SURVEILLANCE WITH ULTRASOUND (US) Sangiovanni, A.
 2010
 42 S1 p. S14-
1 p.
 article
83 20 THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103) Rizzetto, M.
 2010
 42 S1 p. S8-S9
2 p.
 article
84 1 TIME COURSE OF HEPCIDIN RESPONSE TO ORAL IRON TEST CLARIFIES THE ROLE OF HFE AND TFR2 IN IRON SENSING Trombini, P.
 2010
 42 S1 p. S1-
1 p.
 article
85 T.N.16 ACUTE B HEPATITIS AFTER TRANSFUSION OF RED BLOOD CELLS FROM A DONOR WITH OCCULT HEPATITIS B VIRUS INFECTION Spreafico, M.
 2010
 42 S1 p. S20-
1 p.
 article
86 T.N.3 A GENOME-WIDE DNA METHYLATION STUDY IN MONOZYGOTIC TWINS DISCORDANT FOR PRIMARY BILIARY CIRRHOSIS Lleo, A.
 2010
 42 S1 p. S16-
1 p.
 article
87 T.N.20 ALTERED YIN YANG 1/RAF-1 KINASE INHIBITORY PROTEIN RATIO AS A POSSIBLE MOLECULAR MARKER AND THERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA Notarbartolo, M.
 2010
 42 S1 p. S22-
1 p.
 article
88 T.N.39 A 3-MONTHS MULTIDISCIPLINARY LIFESTYLE INTERVENTION REDUCES INSULIN RESISTANCE AND IMPROVES NAFLD Scaglioni, F.
 2010
 42 S1 p. S28-S29
2 p.
 article
89 T.N.35 AN AMPLIFIED T-CELL REGULATORY ACTIVITY IDENTIFIES PATIENTS WITH NORMAL TRANSAMINASES BUT ALSO ADVANCED DISEASE IN HCV-RELATED CHRONIC LIVER DISEASE Ferri, S.
 2010
 42 S1 p. S27-
1 p.
 article
90 T.N.46 A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY Vitale, A.
 2010
 42 S1 p. S31-
1 p.
 article
91 T.N.37 CLUES FOR DIFFERENT PROFILES OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ALCOHOL VS. MIXED ETIOLOGY (ALCOHOL PLUS HCV) LIVER CIRRHOSIS Minazzato, L.
 2010
 42 S1 p. S28-
1 p.
 article
92 T.N.14 COLLAGEN PROPORTIONATE AREA IN ASSESSING THE AMOUNT OF FIBROSIS IN CHRONIC LIVER DISEASE: DOES HIGH RESOLUTION COMPARED TO CONVENTIONAL IMAGE CAPTURING AND ANALYSIS ALTERS ITS RESULTS? Andreana, L.
 2010
 42 S1 p. S19-S20
2 p.
 article
93 T.N.22 CONTRAST IMAGING TECHNIQUES CORRELATE WITH TUMOR GRADING IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS UNDER SURVEILLANCE Iavarone, M.
 2010
 42 S1 p. S22-S23
2 p.
 article
94 T.N.30 CORRELATION BETWEEN FIB-4, LIVER STIFFNESS AND METABOLIC PARAMETERS IN PATIENTS WITH HIV AND HEPATITIS C VIRUS CO-INFECTION Bruno, R.
 2010
 42 S1 p. S25-
1 p.
 article
95 T.N.29 CYTOKERATIN 19: AN IMMUNOHISTOCHEMICAL MARKER TO EARLY DETECT HEPATOCELLULAR CARCINOMA WITH A MORE AGGRESSIVE BEHAVIOR Franceschini, V.
 2010
 42 S1 p. S25-
1 p.
 article
96 T.N.21 DIAGNOSTIC YIELD AND STANDARDIZATION OF FINE NEEDLE BIOPSY IN THE CHARACTERIZATION OF LIVER NODULES IN CIRRHOTIC PATIENTS Sangiovanni, A.
 2010
 42 S1 p. S22-
1 p.
 article
97 T.N.17 DIFFERENTIAL EFFECTS OF PEGYLATED INTERFERON ALPHA THERAPY ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN CHRONIC HEPATITIS B Micco, L.
 2010
 42 S1 p. S20-S21
2 p.
 article
98 T.N.19 DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB: PRELIMINARY RESULTS Zocco, M.A.
 2010
 42 S1 p. S21-
1 p.
 article
99 T.N.49 FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT) De Martin, E.
 2010
 42 S1 p. S32-
1 p.
 article
100 T.N.33 HCV CONTRIBUTES TO INDUCE HEPATIC STEATOSIS THROUGH NUCLEAR LXR RECEPTOR Arciello, M.
 2010
 42 S1 p. S26-
1 p.
 article
101 T.N.32 HCV INFECTION IS ASSOCIATED WITH HIGH COMORBIDITY BURDEN IN EUROPE Garau, M.
 2010
 42 S1 p. S26-
1 p.
 article
102 T.N.8 HEPATIC MITOCHONDRIA OBTAINED FROM 6-OHDA-LESIONED PARKINSONIAN RATS EXHIBIT DECREASED ENERGY CAPACITY AND MEMBRANE POTENTIAL Vairetti, M.
 2010
 42 S1 p. S17-S18
2 p.
 article
103 T.N.11 HEPATIC VEIN TRANSIT TIME (HVTT) OF II GENERATION ULTRASOUND CONTRAST AGENT (USCA): NEW TOOL IN ASSESSMENT OF PORTAL HYPERTENSION. PRELIMINARY RESULTS Siciliani, L.
 2010
 42 S1 p. S18-S19
2 p.
 article
104 T.N.24 IL28B/IFN-λ3RS12979860 POLYMORPHISM IN PATIENTS WITH END STAGE LIVER DISEASE: RELATIONSHIP WITH THE OCCURRENCE OF HCC Bignulin, S.
 2010
 42 S1 p. S23-
1 p.
 article
105 T.N.34 IL6 POLYMORPHISMS PLAY A ROLE IN INFLUENCING THE HISTOLOGICAL PROGRESSION IN PATIENTS WITH CHRONIC HCV INFECTION AND NORMAL TRANSAMINASES Fornasiere, E.
 2010
 42 S1 p. S27-
1 p.
 article
106 T.N.41 INTRACELLULAR GENERATION OF REACTIVE OXYGEN SPECIES AS A CRUCIAL REQUIREMENT FOR DIRECTIONAL MIGRATION OF HEPATIC PRO-FIBROGENIC CELLS Novo, E.
 2010
 42 S1 p. S29-
1 p.
 article
107 T.N.6 INTRAHEPATIC RENIN-ANGIOTENSIN SYSTEM AND LIVER CIRRHOSIS: AN UPDATED REAPPRAISAL Sansoè, G.
 2010
 42 S1 p. S17-
1 p.
 article
108 T.N.10 KUPFFER CELLS REDUCE LIVER IMMUNOPATHOLOGY Sitia, G.
 2010
 42 S1 p. S18-
1 p.
 article
109 T.N.1 LACK OF CFTR AFFECTS THE INNATE IMMUNITY OF THE BILIARY EPITHELIUM AND DETERMINES A TLR4/NF-κB-MEDIATED INFLAMMATORY RESPONSE Fiorotto, R.
 2010
 42 S1 p. S15-
1 p.
 article
110 T.N.43 LEPTIN REDUCES LIVER NECROSIS/APOPTOSIS INDUCED BY ISCHEMIA-REPERFUSION INJURY IN THE RAT, THROUGH ACTIVATION OF STAT-3 PATHWAY Carbone, M.
 2010
 42 S1 p. S30-
1 p.
 article
111 T.N.36 LONG-TERM FOLLOW UP OF PATIENTS WITH ACUTE HEPATITIS C AND SPONTANEOUS RESOLUTION Fasano, M.
 2010
 42 S1 p. S27-S28
2 p.
 article
112 T.N.9 MINIMAL HEPATIC ENCEPHALOPATHY (MHE): SIMPLIFIED DIAGNOSIS AND RELATIONSHIP WITH THE DEVELOPMENT OF OVERT HEPATIC ENCEPHALOPATHY (OHE) Pasquale, C.
 2010
 42 S1 p. S18-
1 p.
 article
113 T.N.7 MULTIPLE CYCLES OF G-CSF ADMINISTRATION TO MOBILIZE BONE MARROW-DERIVED CELLS (BMC) IN PATIENTS WITH END STAGE LIVER CIRRHOSIS Gaia, S.
 2010
 42 S1 p. S17-
1 p.
 article
114 T.N.40 OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS (NASH) Granieri, C.
 2010
 42 S1 p. S29-
1 p.
 article
115 T.N.2 PHARMACOLOGICAL INDUCTION OF PROSTATE APOPTOSIS RESPONSE 4 (PAR-4) PROMOTES APOPTOSIS OF CHOLANGIOCARCINOMA CELLS Torrice, A.
 2010
 42 S1 p. S15-
1 p.
 article
116 T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA Minguzzi, M.
 2010
 42 S1 p. S24-S25
2 p.
 article
117 T.N.13 PREDICTORS OF OUTCOME IN CIRRHOTICS ADMITTED TO INTENSIVE CARE UNIT (ICU); SURVIVORS EXHIBITED SIGNIFICANT RISE OF SERUM SODIUM LEVELS AND A FALL IN LACTATE LEVELS AT 48 HOURS Garcovich, M.
 2010
 42 S1 p. S19-
1 p.
 article
118 T.N.5 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DETECTION OF NEW MUTATIONS AND UNUSUAL MODALITY OF TRANSMISSION Francalanci, P.
 2010
 42 S1 p. S16-
1 p.
 article
119 T.N.12 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOSIS Scarpellini, E.
 2010
 42 S1 p. S19-
1 p.
 article
120 T.N.23 ROSIGLITAZONE INHIBITS HEPATOCELLULAR CANCER CELL GROWTH AND DOWN-REGULATES RUVBL-1: EVIDENCES OF A PPARgamma-INDEPENDENT MECHANISM OF CELL GROWTH INHIBITION Mello, T.
 2010
 42 S1 p. S23-
1 p.
 article
121 T.N.38 SAFETY AND EFFICACY OF PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND HIGH TITRES OF SERUM AUTOANTIBODIES: A SUB-ANALYSIS OF THE MIST STUDY D'Ambrosio, R.
 2010
 42 S1 p. S28-
1 p.
 article
122 T.N.44 SEMAPHORIN7A, A NEW PLAYER IN HEPATIC FIBROSIS: AN IN VITRO AND IN VIVO STUDY De Minicis, S.
 2010
 42 S1 p. S30-S31
2 p.
 article
123 T.N.25 SMALL NODULAR LESIONS IN CIRRHOTIC LIVERS: CHARACTERIZATION WITH CONTRAST ENHANCED ULTRASOUND Giorgio, A.
 2010
 42 S1 p. S23-S24
2 p.
 article
124 T.N.31 SUSTAINED VIROLOGIC RESPONSE PREVENTS THE DEVELOPMENT OF ESOPHAGEAL VARICES IN COMPENSATED, CHILD–PUGH CLASS A HCV-INDUCED CIRRHOSIS. A TWELVE-YEAR PROSPECTIVE FOLLOW-UP STUDY Crosignani, A.
 2010
 42 S1 p. S25-S26
2 p.
 article
125 T.N.42 THE BAGNACAVALLO FATTY LIVER SCORE MAY PREDICT THE PRESENCE OF METABOLIC SYNDROME IN A GENERAL POPULATION: THE PRELIMINARY RESULTS OF A LARGE OBSERVATIONAL STUDY (BAGNACAVALLO-STUDY) Domenicali, M.
 2010
 42 S1 p. S30-
1 p.
 article
126 T.N.18 THE HBV-SPECIFIC T CELL FUNCTION CAN BE RECONSTITUTED IN CHRONIC HBV INFECTION: IMPLICATIONS FOR IMMUNE THERAPIES Laccabue, D.
 2010
 42 S1 p. S21-
1 p.
 article
127 T.N.26 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) FOR HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: INFLUENCE ON PORTAL HYPERTENSION Elia, C.
 2010
 42 S1 p. S24-
1 p.
 article
128 T.N.48 TRANSFORMING GROWTH FACTOR-β1 AND ENDOTHELIN-1 mRNA EXPRESSION IN LIVER CELLS EXPOSED IN VITRO TO CYCLOSPORINE OR SIROLIMUS Occhino, G.
 2010
 42 S1 p. S32-
1 p.
 article
129 T.N.47 TRANSIENT ELASTOGRAPHY EARLY PREDICTS PROGRESSIVE RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION Rigamonti, C.
 2010
 42 S1 p. S31-S32
2 p.
 article
130 T.N.45 TRANSIENT ELASTOGRAPHY VS. NAFLD SCORING SYSTEM IN THE INITIAL EVALUATION OF PATIENTS WITH FATTY LIVER Ceriani, E.
 2010
 42 S1 p. S31-
1 p.
 article
131 T.N.27 TUMOR INFILTRATING CD4 T CELLS AND LIVER INFILTRATING PROINFLAMMATORY T-CELLS AS PREDICTORS OF DISEASE FREE SURVIVAL AFTER RESECTION FOR HCC Cariani, E.
 2010
 42 S1 p. S24-
1 p.
 article
132 T.N.4 UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY Azzaroli, F.
 2010
 42 S1 p. S16-
1 p.
 article
133 T.N.15 UNAWARENESS OF HBV INFECTION IN HOSPITALIZED PATIENTS IN SOUTHERN ITALY Ippolito, A.M.
 2010
 42 S1 p. S20-
1 p.
 article
134 11 VIRTUAL TOUCH ASSESSMENT OF LIVER CIRRHOSIS IN CHRONIC LIVER DISEASE DURING CONVENTIONAL ULTRASOUND SCANNING Piscaglia, F.
 2010
 42 S1 p. S5-
1 p.
 article
135 25 WITHDRAWAL OF PROPHYLAXIS AGAINST HBV IN TRANSPLANTED PATIENTS WITH UNDETECTABLE INTRAHEPATIC TOTAL AND ccc-DNA: CLINICAL OUTCOME AFTER TWENTY MONTHS OF FOLLOW-UP Lenci, I.
 2010
 42 S1 p. S10-S11
2 p.
 article
                             135 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands